The corticospinal tract (CST) can become damaged after spinal cord injury or stroke, resulting in weakness or paralysis. Repair of the damaged CST is limited because mature CST axons fail to regenerate, which is partly because the intrinsic axon growth capacity is downregulated in maturity. Whereas CST axons sprout after injury, this is insufficient to recover lost functions. Chronic motor cortex (MCX) electrical stimulation is a neuromodulatory strategy to promote CST axon sprouting, leading to functional recovery after CST lesion. Here we examine the molecular mechanisms of stimulation-dependent CST axonal sprouting and synapse formation. MCX stimulation rapidly upregulates mTOR and Jak/Stat signaling in the corticospinal system. Chronic stimulation, which leads to CST sprouting and increased CST presynaptic sites, further enhances mTOR and Jak/Stat activity. Importantly, chronic stimulation shifts the equilibrium of the mTOR repressor PTEN to the inactive phosphorylated form suggesting a molecular transition to an axon growth state. We blocked each signaling pathway selectively to determine potential differential contributions to axonal outgrowth and synapse formation. mTOR blockade prevented stimulation-dependent axon sprouting. Surprisingly, Jak/Stat blockade did not abrogate sprouting, but instead prevented the increase in CST presynaptic sites produced by chronic MCX stimulation. Chronic stimulation increased the number of spinal neurons expressing the neural activity marker cFos. Jak/Stat blockade prevented the increase in cFos-expressing neurons after chronic stimulation, confirming an important role for Jak/Stat signaling in activity-dependent CST synapse formation. MCX stimulation is a neuromodulatory repair strategy that reactivates distinct developmentally-regulated signaling pathways for axonal outgrowth and synapse formation.
Introduction
Brain and spinal cord injury (SCI) interrupt neural connections between the motor centers that initiate and regulate movements from the spinal circuits that produce movement, resulting in weakness or paralysis. To abrogate these motor impairments, we must reconnect the brain and spinal cord. The corticospinal tract (CST) is a key motor pathway for controlling movements (for review, see (Lemon, 2008; Porter and Lemon, 1993) ) and an important target for repair (Baker et al., 2015; . Adult mammalian neurons have a limited ability to regenerate damaged axons due to the developmental loss of an intrinsic capacity to initiate axonal outgrowth (Jacobson et al., 1986; Park et al., 2008; De-Fraja et al., 1998; Hoffman, 1989; Laub et al., 2005; Sun and He, 2010) . And what limited capacity that remains may be further reduced by extrinsic inhibitory factors in the damaged environment (Caroni and Schwab, 1988; Fitch and Silver, 2008; McKerracher et al., 1994; Mukhopadhyay et al., 1994) . Although unable to regenerate lost axons, undamaged CST neurons have some capacity for local axonal outgrowth or sprouting. Since brain or spinal cord injury is usually incomplete (Chen et al., 2016; Raineteau and Schwab, 2001) , the remaining spared CST axons can grow collaterals in response to the injury and contribute to functional recovery (BrusRamer et al., 2007; Thallmair et al., 1998; Weidner et al., 2001) . Unfortunately, this innate sprouting capacity also is limited; without further intervention, injury-dependent sprouting is insufficient to restore control after severe injury (Carmel et al., 2010; Maier et al., 2008) .
CST axonal outgrowth and synapse formation is regulated by neural activity during development (Friel and Martin, 2007b; Salimi et al., 2008) . Activity can be exploited in the adult brain to promote CST axonal outgrowth. Chronic daily electrical stimulation of the motor cortex (MCX), the principal source of CST neurons (Lemon, 2008) , is a neuromodulatory strategy that augments contralateral and ipsilateral CST axon sprouting in intact adult rats and is additive when applied to rats with unilateral pyramidotomy (Brus-Ramer et al., 2007) . This stimulation-dependent ipsilateral CST sprouting, as well as sprouting into brain stem nuclei is sufficiently robust following chronic MCX stimulation to restore movements after injury (Carmel et al., 2010; Carmel et al., 2013) . Moreover, reversible inactivation of the ipsilateral MCX in chronically-injured animals reinstates the motor impairment , showing a key role for the ipsilateral MCX descending projection in motor recovery. Thus, MCX stimulation is a promising neuromodulatory strategy that can be harnessed for CST repair after injury.
In this study we examine the molecular mechanisms of MCX stimulation-dependent CST axonal sprouting and synapse formation. To eliminate the contributions of injury-dependent sprouting, we studied activity-dependent CST axonal sprouting by applying electrical stimulation to the MCX of uninjured adult rats. We focus on the capacity for electrical stimulation to upregulate neuron-intrinsic factors for CST axon sprouting. Whereas there are many targets for enhancing intrinsic factors to augment axonal outgrowth (Blackmore et al., 2012; Moore et al., 2009) , we examine the mTOR and Jak/Stat pathways, which are highly active during development and are downregulated in maturity (Dziennis and Alkayed, 2008; Hentges et al., 2001; Lipton and Sahin, 2014; Takeda et al., 1997) . Signaling in these pathways is critically involved in injury-driven sprouting and axon regeneration. In maturity mTOR activation by downregulation of the repressor PTEN leads to CST axon regeneration (Geoffroy et al., 2015; Lee et al., 2014; Park et al., 2008; Sun et al., 2011) . Stat3 activation in maturity, via SOCS3 deletion, results in optic nerve axon regeneration (Muller et al., 2009; Smith et al., 2009; Sun et al., 2011) . We hypothesize that mTOR and Stat3 are upregulated by MCX electrical stimulation and are necessary for the consequent CST axonal sprouting and synapse formation.
We show that stimulation acutely activated the mTOR and Jak/Stat pathways in the corticospinal system. Chronic stimulation, which leads to CST axon sprouting, shifted the equilibrium of the mTOR repressor PTEN to an inactive phosphorylated form, as well as further enhanced mTOR and pStat3 activity. This suggests a molecular transition to an axon growth state. Selective pathway blockade revealed that mTOR activation is necessary for CST activity-dependent sprouting but, surprisingly, that Stat3 is necessary for formation of CST presynaptic sites/ synapses, not axon sprouting. MCX stimulation is a neuromodulatory repair strategy that recapitulates key intracellular physiological conditions to activate developmentally-regulated molecules for axonal outgrowth and synapse formation.
Materials and method

Animal groups
All animal experiments were conducted in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. All animal protocols were approved by the City College Institutional Animal Care and Use Committee. Adult female Sprague Dawley rats weighing between 225 and 275 g were housed under a 12 h light/dark cycle in the institutional vivarium and provided with water and food. All surgeries were performed under general anesthesia (90 mg/kg ketamine, 10 mg/kg xylazine) administered intraperitoneally in aseptic condition.
Anterograde labeling of CST axons
Rats were anesthetized and placed in a stereotaxic frame (Kopf Instruments). Body temperature was maintained at 37°C by a heating blanket. Following craniotomy to expose the forelimb primary MCX, 7 pressure injections (300ηL/each) of biotinylated dextran amine (BDA; 10,000 MW; Molecular Probes; 10% in 0.1 M PBS) were made in the forelimb MCX (depth 1.5 mm, lateral 2.5 to 3.5 mm; rostral: 0.5 to 2.5 mm; separated by 0.5 mm each injection site) using a Hamilton syringe (33 gauge needle). Tracer was injected using a micropump (WPI). Animals survived for two weeks.
Electrode implantation and stimulation
After completing tracer injections, a stainless steel stimulating electrode was placed over the dura covering the forelimb MCX (BrusRamer et al., 2007) . The electrode wires were bent into an "L" shape with the bottom of the L deinsulated. We placed the angle of the Lshaped electrodes 2 mm and 3.5 mm lateral to bregma, respectively, with the exposed contact extending rostrally over the forelimb M1. To confirm electrode placement, we stimulated the MCX to provoke a motor response. A constant current stimulator (A-M systems) was used to deliver trains of stimuli (0.2 msec duration, 333 Hz, 45 msec, every 2 s). We adjusted the current to the minimal value to evoke a contralateral forelimb movement, which was typically (1.1 to 2 mAmps); no ipsilateral forelimb movement was observed. The electrode was secured using microscrews (Plastics One) and dental acrylic cement.
Rats were stimulated 6 h/day for either one or ten days (Brus-Ramer et al., 2007; Carmel et al., 2010) using the same stimulation parameters described above. Animals were awake for daily stimulation and were attached to the stimulator via a commutator (Plastics One) to prevent the wires from twisting as they moved about the cage. Initial threshold current for stimulation to evoke forelimb movement was determined and stimulation continued at this current for the duration of the 6 h period. For our 10-day stimulation, the threshold current was checked daily. Whereas there were day-to-day fluctuations (e.g., in the range of 0.1-0.3 mAmp), we did not observe a trend to higher or lower thresholds.
Pathway blockade
The functional requirement of the mTOR and the JAK/STAT pathways in CST sprouting and CST synapse formation were examined by blocking these pathways separately. We used rapamycin (10 mg/kg, IP, every 48 h; LC Labs) to block mTOR signaling (Park et al., 2008) and AG490 (20 mg/kg, IP, daily, LC Labs) to block JAK/STAT signaling (Iwamaru et al., 2007) .
Western blotting
For Western blotting and quantitative PCR, animals were euthanized within 30 min after cessation of stimulation. The stimulated and non-stimulated MCXs were dissected into ice cold HBBS (Hank's balanced salt solution; Invitrogen). The forelimb M1 region was placed in a microtube and homogenized promptly in N-PER buffer (Invitrogen) supplemented with a protease-inhibiting cocktail (Invitrogen). Bradford protein analysis was carried out in order to measure protein concentration and approximately 50 μg of protein was subjected to SDSacrylamide-bisacrylamide gel electrophoreses along with a protein ladder (Crystalgen) for size comparison. Following electrophoresis, the protein bands were transferred to PVDF membrane (Millipore) and probed against the primary antibodies. An ECL chemiluminescent system (Cell Signaling Technology) was used to develop the Western blots. The following primary antibodies were used: phos-S6 (S235/ S236) at 1:1000; total S6 at 1:1000; phos-Stat3 (Y705) at 1:500; total Stat3 at 1:1000 (Cell Signaling Technology); phos-PTEN (S380) at 1:500; total PTEN at 1:1000 (Santa Cruz Biotech); and GAPDH at1:5000 (Sigma Aldrich). Secondary antibodies include anti-mouse and antirabbit at 1:10,1000 (Vector Laboratories).
Reverse transcription and quantitative PCR
Animals were euthanized within 30 min after cessation of stimulation. The stimulated and non-stimulated M1 were dissected into ice cold HBBS (Hank's balanced salt solution; Invitrogen). The forelimb M1 region was homogenized in TRI reagent (Molecular Research Center) and total mRNA was isolated following the manufacturer's instruction. cDNA was reversetranscribed from total RNA with a cDNA synthesis kit (OriGene). The primers used for PCR amplification of rat Survivin were Fwd 5′-ACTGCCCTACCGAGAATGAG -3′ and Rvrs 5′-ACGGTCAGTTC TTCCACCTG -3′ and GAPDH forward 5′-AAGTGGACATTGTTGCC ATC-3′ and reverse 5′-CATACTCAGCACCAGCATCA-3′. An equal amount of cDNA template was used for each PCR reaction. A SYBR green/DNA polymerase PCR kit was used (Roche) to carry out quantitative PCR reactions in a thermocycler (Eppendorf Realplex). Values obtained from SYBR green count were recorded, transcript levels were normalized against rat GAPDH signal and results were reported as relative increase in mRNA expression in reference to control values (Livak and Schmittgen, 2001 ).
Immunohistochemistry
Animals were deeply anesthetized and transcardially perfused with saline, followed by 4% paraformaldehyde. The cervical spinal cord and brain were dissected, post-fixed in 4% paraformaldehyde for 1 to 2 h and transferred to 20% sucrose (overnight at 4°C). Frozen sections were cut transversely at 40 μm thickness using a sliding microtome. BDA was visualized with 1% avidin-biotin complex reagent (ABC kit; Vector Laboratories), followed by the chromogen diaminobenzidine (DAB, Sigma) or streptavidin-FITC conjugate. Primary antibodies used in immunofluorescence staining include: vGlut1 at1:10 (NeuroMab); phos-S6 (S235/S236) at 1:1000 (Cell Signaling Technology); Survivin at 1:400 (Cell Signaling Technology); NeuN at 1:1000 (EMD Millipore) and cFos at 1:1000 (Cell Signaling Technology). Several different commercial antisera against pStat3/Y705 were tried but failed to produce immunostaining in our hands; thus, we decided to examine the levels of Survivin (Sehara et al., 2013) , a direct transcriptional target of pStat3, to assess pStat3 activity in stimulated MCX neurons. Appropriate secondary antibodies conjugated to FITC, Cy3 or Cy5 were used. DAPI (Cell Signlaing Technology) nuclear staining was done at final concentration of 1ηg/μl. Sections were visualized and imaged digitally using a Zeiss LSM 710 or 880 meta confocal microscope.
Spinal cord CST presynaptic site determination
Spinal cord sections at the C7 level were fluorescently-labeled for BDA and vGlut1 and photographed using a confocal microscope (Zeiss, LSM 710). Z-interval feature was used to capture ipsilateral CST gray matter axons. Photographs were taken at 40× magnification, with a frame size of 512 × 512 and 0.42 μm pixel size. Image J (NIH) was used to determine BDA labeled axon length and the number of pre-synaptic boutons, which was determined by the presence of BDA and VGlut1 colocalization.
Stereological quantification of pathway activation in cells and neurons
In order to obtain quantitative estimates of the density of cells in the motor cortex and/or the spinal cord expressing cFos and markers for mTOR and Jak/Stat signaling pathways, we used the unbiased stereological method, the optical fractionator (West et al., 1991) , and StereoInvestigator software (MBF). cFos, NeuN, pS6, DAPI and Survivinpositive cells were counted on 4 to 6 randomly-chosen sections from 3 to 7 animals, depending on the analysis, at 200× magnification. Sections containing DAB staining were counted directly under the microscope. Fluorescently-labeled sectioned were imaged first at 200× magnification, and then counts were obtained from the micrographs to prevent photo-bleaching, similar to our earlier study (Chakrabarty et al., 2009 ). Counts were made using a grid size of 300 and frame size of 300 and on a region of interest basis. We counted cells, across all animals, in the portion of the forelimb M1 under and adjacent to the stimulating or sham electrode. Cell densities were calculated using the unbiased cell count estimate and the volume of each section obtained from the StereoInvestigator software.
Anatomical data acquisition and analysis of ipsilateral CS axon terminations
The Neurolucida tracing system (MBF Bioscience, Williston, VT) was used to measure axon length and varicosity number. These measurements were then used to create topographic density maps to determine changes in ipsilateral axon terminations. Axon length and varicosity number were measured in five transverse sections for each animal by laboratory personnel blinded to animal group. For construction of topographic density maps ("heat maps"), digital tracings of individual sections were corrected for orientation and aligned with one another according to fiduciary marks (intersection between the gray matter above the central canal and the dorsal median septum) before being exported and quantified using custom programs written in Matlab (MathWorks, Natick, MA), as previously reported (Brus-Ramer et al., 2007) .
Retrograde labeling of CST neurons
We retrogradely labeled CST neurons with tetramethyl rhodamine (TMR, Invitrogen) for identification. 10 to 12 injections were made unilaterally in the C5-C8 segments. Injections were separated by 1 mm rostrocaudally and made using a micropump (WPI). Each injection was 300ηl at a depth of 0.9 mm and 0.5 mm away from the dorsal roots and toward the midline. All animals were allowed to survive for two weeks post-injection. Injections produced robust contralateral retrograde labeling. As in previous studies, ipsilateral labeling was sparse (Umeda and Isa, 2011) . Analysis was performed on ipsilateral-projecting CST neurons.
CST neuron volume determination
CST neuron volume was examined stereologically from high resolution confocal micrographs of neurons using Nucleator (MBF Bioscience). The Optical Fractionator program (MBF Bioscience) was used for random sampling of target CST neurons. Four rays were used and the points where the rays intersected with the edge of neuron were marked and the program generated an estimated cellular volume. Approximately 75 CST neurons were sampled per animal and 3 animals were used per group. Analyses were conducted by laboratory personnel blinded to animal group.
Statistics and general data analyses
Anatomical measurements were performed by laboratory staff blinded to animal group. Statistical analyses were performed using Prism 5 (GraphPad Software), Excel (Microsoft) and KaleidaGraph (Synergy Software). The differences between groups were performed using either Mann-Whitney t-Test or one-way ANOVA with Tukey's post-hoc, Dunnett's and Sidak's multiple comparison tests.
Results
MCX stimulation activates neurons of the targeted hemisphere
MCX stimulation activates the forelimb representation selectively, based on evoking forelimb not face or hind limb movements at threshold and producing robust forelimb EMG responses (Brus-Ramer et al., 2007) . Using a morphological marker of neuronal activity, cFos, stimulation activated MCX unilaterally (Fig. 1 ). There was approximately a 10-fold increase in cFos-expressing cells 30 min after cessation of 6 h of stimulation in the stimulated hemisphere compared with the non-stimulated hemisphere under all conditions (Fig. 1A , B: ****p < .0001; 1 day vs. 1 day non-stim and 10 day vs 10 day nonstim; One way ANOVA with Sidak's test). Co-labeling with a neuronspecific marker, NeuN, revealed a similar 10-fold increase in activated neurons ( Fig. 1C : **p = .0011; 1 day vs. 1 day non-stim & *p = .028 10 day vs. 10 day non-stim; One way ANOVA with Sidak's test.). The inset shows a representative cFos-labeled neuron. Approximately half of all cFos expressing cells were neurons in both stimulated and non-stimulated hemispheres (Fig. 1D ).
MCX stimulation activates the mTOR signaling pathway
We next asked whether MCX stimulation activated signaling molecules shown to be necessary for axon regeneration and outgrowth. We first examined mTOR activity because it is known to play a significant role in axon outgrowth during development and after injury (Jaworski and Sheng, 2006; Lipton and Sahin, 2014; Liu et al., 2010; Park et al., 2008) . We looked at the level of ribosomal protein S6 phosphorylated at S235/S236 residues (pS6) to determine mTOR pathway activation (Liu et al., 2010) . One day of stimulation produced a significant increase in pS6 + cells in the stimulated MCX compared to sham ( Fig Robust activity-dependent sprouting of CST axons and formation of axon varicosities occurs after chronic stimulation in intact animals (Brus-Ramer et al., 2007) . We next determined the effect of 10 days of chronic MCX daily stimulation on mTOR activation. Chronic stimulation activated the motor cortex unilaterally, similar to 1 day of stimulation as demonstrated by cFos expression ( Fig. 1C ; *p = .028; 10 day vs 10 day non-stim). There was no further increase in the number of cFos + neurons (p > .99; ANOVA with Sidak's test). The number of pS6 + cells after 10 days of stimulation was significantly higher than controls ( Fig. 2A ; **p = .0033; One way ANOVA with Tukey's multiple comparisons test) but not greater than for 1 day. For the 10-day stimulated group, we plotted the locations of pS6 + cells in the cortex ( Fig. 2A, inset) . MCX stimulation increased pS6 preferentially in layer 5 (Fig. 2E) , which is where CST neurons are located. Double-labeling with the neuronal marker NeuN showed that, compared with sham controls, chronic MCX stimulation produced a significant increase in the number of pS6 + neurons in the stimulated but not sham MCX ( Fig. 2F; *p = .0357; Mann-Whitney's t-Test). However, the percentage of pS6 + neurons, as determined by NeuN+pS6 double labeling, remained the same between the sham and chronically stimulated groups (Fig. 2G ). This indicates that the chronic stimulation-driven increase in mTOR activity is observed in both neurons and non-neuronal cells, in the same proportion. In a subset of animals (N = 3) we retrogradely labeled CST neurons following tracer injection at the C4 to C8 segment of the spinal cord (Fig. 2H , ipsilateral) and confirmed pS6 immuno-staining in CST neurons. Western blot data show that the ratio of pS6 to total S6 expression level is significantly higher after 10 days compared with 1 day of stimulation ( Fig. 2C ; ***p = .0003). Since the number of pS6 + cells
is not different at the two time-points ( Fig. 2A) , the level of mTOR activation increased during the stimulation period rather than the size of the responding cellular population. As seen with one day stimulation, administration of rapamycin during chronic stimulation also suppresses mTOR activity ( Fig. 2A ;**p = .0012; 10 day vs. 10 day+Rapa; One- ). **p = .0011 for 1 day stim vs. 1 day non-stim; *p = .028 for 10 day stim vs. 10 day non-stim; *p = .0356 for 10 day + Rapa vs. Rapa non-stim; *p = .0316 for 10 day + AG490 vs. AG490 non-stim; Oneway ANOVA with Sidak's test; n = 4 rats per group. Inset shows a representative c-Fos + neuron in MCX after 10 days of stimulation (c-Fos, Cy3, red. NeuN, FITC, green; combined c-Fos PTEN is a negative regulator of the mTOR signaling pathway (Yilmaz et al., 2006; Zhang et al., 2006) . mTOR hyperactivity following PTEN deletion results in abnormally large cell bodies of neurons (Chalhoub et al., 2006; Kwon et al., 2003) . We asked whether the observed increase in mTOR activity in the chronically stimulated rat brain resulted in a morphological change in CST neurons, identified by retrograde labeling, during the period when there is activity-dependent sprouting. A stereological analysis of CST neurons revealed that mTOR hyperactivation due to chronic stimulation has no effect on CST neuron soma volume (Fig. 2I ). This suggests that growth is selective for axons at this time point.
Since we observed an increase in mTOR activity following 1 and 10 days of MCX stimulation, we asked if this was associated with a change in PTEN expression levels. Surprisingly, Western blot analysis (Fig. 3A) revealed that total PTEN expression levels did not change across the three conditions (Fig. 3B) . Instead, the level of PTEN phosphorylated at residue Ser380 (Das et al., 2003) increased following chronic but not 1 day of stimulation (Fig. 3C ; *p = .0173, One-way ANOVA with Tukey's multiple comparisons test). When phosphorylated, PTEN becomes less active (Das et al., 2003) . This suggests that chronic MCX stimulation shifts the equilibrium of PTEN activity to increase the ratio of the inactive PTEN to total PTEN. To summarize, our findings show that chronic (10 days) MCX stimulation produces a larger activation in stimulation-dependent mTOR signaling than after 1 day and suggest that the increase in mTOR is partly driven by upregulation of the inactive state of the repressor protein PTEN.
MCX stimulation enhanced pStat3 levels
We next examined the activity levels of the Stat3 transcription factor of the Jak/Stat pathway after 1 day stimulation using immunostaining of the direct Stat3 transcriptional target, Survivin (Carpenter and Lo, 2014; Sehara et al., 2013 ). There was a 3 fold increase in Survivin + cells in MCX ( Fig. 4A ; ****p = .0001; One way /μm 3 ) of cortical section for the different experimental conditions. Asterisks denote significant difference. *p = .0209 (Sham vs. 1 day); **p = .0033 (Sham vs.10 day); **p = .0012 (10 day+Rapa vs. 10 day); One-way ANOVA with Tukey's multiple comparisons test. Sham group, n = 6 rats; 1 day group, n = 4 rats; 10 day group, n = 11 rats; 10 day stimulation+rapamycin, n = 5 rats. (Inset) Micrographs showing pS6-immunostained cells in MCX of the stimulated and non-stimulated sides. The bottom row corresponds to the expanded region shown in the top row. Scale bar = 200 μm (for top row sections); 400 μm (for bottom row sections). (B) Western blot of cortical lysates probed with anti-sera against pS6, total S6 and the housekeeping protein, GAPDH. (C) Mean intensities of pS6 expression, presented as ratios of pS6 to total S6. *p = .0386 (Naïve vs. 1 day); *p = .0142 (1 day stim vs. 1 day stim+Rapa); ***p = .0003 (Naïve vs. 10 day); One-way ANOVA with Tukey's multiple comparisons test. Naïve, 1 day and 1 day+Rapa groups, n = 4 rats; 10 day and 10 day+Rapa groups, n = 3 rats. Inset shows Western blot of total lysate from stimulated cortex with AG490 treatment, probed using anti-sera against pS6, total S6, GAPDH. ANOVA with Dunnett's multiple comparisons test). The intracortical laminar distribution of Survivin + cells was broad but densest in lamina 5 (Fig. 4B ). Western blot data (Fig. 4C, D) show that MCX stimulation resulted in a significant increase in the level of pStat3 ( Fig. 4D ; *p = .0304, One-way ANOVA with Tukey's multiple comparisons test) with no change in total Stat3 levels (Fig. 4E) . Blockade of Stat3 phosphorylation with AG490, which did not affect the number of cFos + neurons ( Fig. 1C ; *p = .0316), prevented the activity-dependent increase in pStat3 expression levels in MCX ( Fig. 4C, D ; *p = .0297).
Using quantitative PCR, we further confirmed that AG490 administration abrogated pStat3 activity by examining the mRNA expression levels of Survivin, its transcriptional target (data not shown; 1 day stimulation versus naive, p = .0011; 1 day stimulation versus 1 day stimulation+AG490, p = .0002; ANOVA with Tukey's test; n = 3 rats per group). In our 1-day stimulated rats, we observed a three-fold increase in Survivin mRNA levels, compared to their AG490 treated counterparts (p = .0002). We also examined the level of Stat3 pathway activation at 10 days, which is during the activity-dependent growth stage. We found that chronic MCX stimulation also produced a significant increase in Survivin-positive cells in MCX ( Fig. 4A ; *p = .0185; One way ANOVA with Dunnett's multiple comparisons test) and, similar to 1 day of stimulation, these cells are concentrated in layer 5 of the MCX, where CST neurons are located (Fig. 4B) . Retrograde labeling showed that chronic stimulation increased Survivin expression in CST neurons projecting to the cervical enlargement (Fig. 4F) (Fig. 4C) shows that chronic MCX stimulation increased the ratio of active Stat3 in the cortex (**p = .0012), representing a further increase in Jak/Stat activity in both neuronal and non-neuronal cells during the chronic stimulation period, with no change in total Stat3 levels, compared with sham and 1 day of stimulation (Fig. 4D, E) . Thus, we find that Jak/Stat signaling is also activated to a greater extent as a result of chronic MCX stimulation compared to 1 day of stimulation. We verified that blocking Jak/Stat activity did not affect mTOR activity. Administration of AG490 does not abrogate pS6 expression in MCX (data not shown; *p = .0286; Sham + AG490 vs. 10D + AG490; Mann Whitney t-test. n = 4 rats per group). Additionally, AG490 administration does not interfere with pS6 activation following MCX stimulation (Fig. 2C inset) indicating that AG490 does not significantly affect activation of the mTOR pathway. Similarly, rapamycin administration does not interfere with Stat3 stimulation-dependent activation as confirmed by pStat3 levels (Fig. 4D inset) .
CST axon sprouting requires activation of the mTOR pathway but not the Jak/Stat pathway
We next determined whether blocking stimulation-induced activation of mTOR signaling prevented CST axon sprouting. We focused on ipsilateral stimulation-dependent outgrowth, which has been shown to associate with behavioral recovery after unilateral pyramidal tract lesion (Carmel et al., 2010 . In chronically-stimulated rats, we anterogradely traced the CST from the stimulated MCX (Fig. 5A ) and compared ipsilateral cervical CST label with that of sham animals. Similar to our earlier study (Brus-Ramer et al., 2007) , MCX stimulation promoted ipsilateral CST axon growth (Fig. 5B) . Regional axon density maps show both an increase in the overall area of projections and the local density (Fig. 5C ). As previously reported (Brus-Ramer et al., 2007) , stimulation significantly increased total ipsilateral axon length, by approximately 2-fold ( Fig. 5D ; **p = .0076; One-way ANOVA with Tukey's multiple comparisons test). mTOR pathway deactivation with rapamycin completely blocked activity-dependent CST axonal sprouting (Fig. 5 C,D ; **p = .002) even though cFos expression shows that there continued to be an increase in MCX activity during stimulation ( Fig. 1C ; *p = .0356). Remarkably, blocking Stat3 activation with AG490 did not suppress axonal outgrowth in the ipsilateral spinal gray matter (Fig. 5C, D ; *p = .0349 compared to sham). Our findings indicate that mTOR, not Jak/Stat, activation is necessary for activity dependent axonal sprouting.
3.5. The Jak/Stat pathway plays a key role in activity-dependent presynaptic site remodeling Chronic MCX stimulation in rats not only results in CST axonal outgrowth but increased numbers of putative axon synapses, assayed in an earlier study as axonal varicosities, and larger MCX-evoked ipsilateral motor responses (Brus-Ramer et al., 2007) . We next examined the role of activity-dependent mTOR and Jak/Stat MCX activation on establishment of CST synaptic contacts in the spinal cord after chronic stimulation. We were particularly interested in determining if blocking Jak/Stat activation, which does not impede activity-dependent CST axonal outgrowth, affects activity-dependent synapse formation. To assay CST presynaptic sites we co-labeled CST axons with an antibody to vGlut1 (Fig. 6A, inset) , the glutamate vesicular transporter present in CST neurons (Alvarez et al., 2004) . We selected a region of interest within the medial intermediate zone of the ipsilateral CST projection field, corresponding to the high axon density focus (Fig. 5C ), for analysis of double-label presynaptic sites. 10 days of MCX stimulation produced a significant increase in CST presynaptic sites (Fig. 6A *p = .0417; One-way ANOVA with Tukey's multiple comparisons test). mTOR blockade with rapamycin, which abrogated the increase in axon length, not surprisingly also blocked presynaptic sites ( Fig. 6A ; **p = .0068). By contrast, pStat3 blockade, which did not affect axonal outgrowth, fully blocked the increase in presynaptic sites with chronic stimulation (Fig. 6A , *p = .0224) even though stimulation under these conditions continued to activate cFos expression in the MCX (Fig. 1A ; ****p < .0001). We also conducted a topographic analysis of ipsilateral CST presynaptic sites by examining axonal varicosities, defined as approximately 3 times the non-varicose axon diameter. This is a practical way to assay putative CST synaptic contacts throughout the entire territory in which axonal outgrowth was measured. A large percentage of CST axonal varicosities colocalize presynaptic markers (Friel et al., 2012; Meng et al., 2004) . Stimulation produced a significant increase in the regional density of ipsilateral CST axon varicosities, coextensive with the increased axon density (Fig. 6B ). mTOR blockade with rapamycin, in addition to preventing activity-dependent axon sprouting also prevented the increase in varicosities (Fig. 6B) . Blockade of Stat3 activation with AG490 prevented formation of CST varicosities within the termination field (Fig. 6B ) despite having no effect on axonal outgrowth (Fig. 5C) .
We determined if the increase in CST presynaptic sites produced by chronic MCX stimulation was associated with increased ventral spinal activation and if Jak/Stat signaling blockade prevented an activation increase. We used spinal cFos expression to determine the response to chronic stimulation. Nuclear cFos labeling was observed in spinal interneurons (e.g., choline acetyltransferase-positive; Fig. 6C , middle image) and occasionally in motor neurons (Fig. 6C, right) . We quantitatively analyzed cFos-expressing cells in the ventral spinal gray matter, which is comprised of the intermediate zone and motor pool regions. This is where activity-dependent ipsilateral axonal sprouting and presynaptic bouton formation is strongly evident (Figs. 5C, 6B ) and activation by MCX stimulation is likely to lead directly to muscle activation through connections with premotor interneurons and motor neurons (Asante and Martin, 2013; Goetz et al., 2015) . Similar to published findings (Curfs et al., 1996) , sham controls had few ventral cFos + cells (Fig. 6D ). Ten days of chronic MCX stimulation resulted in a significant increase in the cFos-expressing cells in the ipsilateral ventral cervical gray matter ( Fig. 6D ; *p = .0203; sham vs. 10-day; One-way ANOVA with Tukey's multiple comparisons test), also shown by density mapping (Fig. 6E) . Importantly, this response of chronic MCX stimulation was prevented when Jak/Stat signaling was blocked with AG490 ( Fig. 6D ; *p = .0158 10 day vs. 10 day+AG490, E). Similar to published findings for kianate-induced MCX activation (Curfs et al., 1996) , 6 h of MCX stimulation acutely produced sparse cFos expression in the ventral horn similar to that of non-stimulated controls (data not shown). AG490 did not prevent MCX stimulation from robustly activating muscle. MCX-evoked responses of the extensor carpi radialis (ECR) muscle-over a range of stimulation, from threshold to 1.6 times threshold-were unchanged after 10 days of AG490 treatment (Fig. 6F) . Moreover, the current threshold for evoking a contralateral forelimb movement before and during AG490 treatment were unchanged (p = .38). Chronic MCX stimulation also increased contralateral spinal cFos expression (data not shown). This is expected since the contralateral CST projection is much denser than the ipsilateral projection and evidence suggests that chronic MCX stimulation also increases the contralateral projection (Brus-Ramer et al., 2007; Carmel et al., 2013) . These finding suggest that Jak/Stat signaling is necessary for establishing functional presynaptic sites after chronic MCX stimulation. Jak/ Stat pathway blockade seems not to affect existing synapses, since the number of cFos + neurons after AG490 treatment was not lower than
sham, but may preferentially act to prevent the activity-dependent formation of new synapses.
Discussion
Augmenting neural activity by MCX stimulation upregulates the activity marker cFos in MCX and, in turn, the mTOR and Jak/Stat signaling pathways necessary for CST axonal outgrowth and presynaptic bouton formation, respectively. Whereas blockade of either signaling pathway had no effect on cFos expression, suggesting no effect of pathway activation on MCX activity, mTOR blockade abrogated CST axonal outgrowth and blocking Jak/Stat signaling prevented activity-dependent spinal synapse formation. mTOR is associated with retinal ganglion cell and CST axon regeneration, as well as CST injurydependent reactive sprouting (Lee et al., 2014; Li et al., 2016; Liu et al., 2010; Park et al., 2008; Sun et al., 2011) . We show that CST sprouting provoked by MCX electrical stimulation also depends on mTOR signaling. Surprisingly, Jak/Stat signaling, despite promoting retinal ganglion cell axonal outgrowth (Smith et al., 2009; Sun et al., 2011) and supporting CST axon outgrowth with mTOR (Jin et al., 2015) , does not seem to play a role in stimulation-dependent CST outgrowth. Rather, we have shown that it is necessary for establishing presynaptic sites, and possibly functional synapses, since blocking pStat3 also prevented the increase in stimulation-dependent cFos expression in the ventral spinal cord. Because MCX stimulation drives both mTOR and Jak/Stat signaling for axonal outgrowth and presynaptic site formation suggests that neural activity-promoted through MCX neuromodulation-may coordinate these two functions. Asterisks denote significant differences from the Sham group. **p = .0076 (Sham vs 10 day); *p = .0349 (Sham vs 10 day +AG490); **p = .002 (10 day vs. 10 day+Rapa); *p = .0104 (10 day+Rapa vs. 10 day+AG490); One-way ANOVA with Tukey's multiple comparisons test. Sham group, n = 5 rats; 10 day group, n = 6 rats; 10 day+rapamycin group, n = 5 rats; 10 day+AG490 group, n = 4 rats.
Developmental downregulation of mTOR and Jak/Stat limits axon regeneration
Both mTOR and Jak/Stat are active during development and have been shown to be necessary for normal brain and neural circuit development (Dziennis and Alkayed, 2008; Hentges et al., 2001; Nie et al., 2010; Takeda et al., 1997) . mTOR activity is reduced in maturity and maintained at a low basal level necessary for cellular homeostasis and synaptic plasticity (Beaumont et al., 2001; Casadio et al., 1999) . Likewise, active Stat3 (phosphorylated at Y705 by Janus kinase) expression is reduced in the adult brain and is only present in certain highly plastic brain regions and areas undergoing self-renewal (Doetsch et al., 1999; Eriksson et al., 1998) . The switch from high to low basal activity levels of mTOR and Jak/Stat3, among other axon growth-promoting pathways and genes, is thought to contribute to the lack of axon regenerative capacity of mature neurons (He, 2010; Moore et al., 2011; Sun and He, 2010) .
Stimulation reactivates a developmental growth program
In several CNS injury models, mTOR and Stat3 upregulation has been shown to be sufficient for significant axonal outgrowth (Muller et al., 2009; Sun et al., 2011) . Corticospinal system stimulation during development and maturity lead to CST spinal gray matter axonal outgrowth in intact animals and after manipulations that reduce the spinal projections of the non-stimulated MCX/CST (Brus-Ramer et al., 2007; Carmel et al., 2010; Salimi et al., 2008; . mTOR activation, possibly triggered via calcium influx associated with stimulation (Li et al., 2016) , was shown by elevated MCX pS6 protein levels and the presence of increased numbers of pS6-positive neurons in layer 5 of the stimulated MCX. Similar to mTOR, electrical stimulation augments JAK activity as shown by significant increases in phosphorylated Stat3 protein levels in the cortex and increases in both the mRNA levels of its direct transcriptional target Survivin and larger numbers of Survivin + neurons in MCX (Carpenter and Lo, 2014) . These findings indicate that MCX stimulation re-activates components of a developmental cell growth program, which helps to explain how phasic activation enhances the corticospinal system's intrinsic capacity to initiate axonal outgrowth and formation of new connections.
4.3. Dual mechanisms for activity-dependent sprouting and synapse formation mTOR blockade abrogates the axonal outgrowth produced by chronic MCX stimulation, indicating an important role in directing activity/stimulation-dependent CST sprouting. Remarkably, Stat3 blockade has no effect on activity-dependent axonal sprouting. These findings, together with the genetic upregulation of mTOR and consequent CST axon regeneration and sprouting (Geoffroy et al., 2015; Lee et al., 2014; Liu et al., 2010) , suggests that mTOR upregulation is necessary and sufficient for this activity-dependent CST axon sprouting. Recently, it has been shown that light-induced activity changes in retinal ganglion cells leads to activation of mTOR and associated optic nerve axonal outgrowth (Li et al., 2016; Lim et al., 2016) . Since Stat3 blockade abrogated only the increase in CST synapses associated with MCX stimulation and not axon lengthening itself, Stat3 has a distinct function from that of mTOR. The role of mTOR in establishment of CST synapses during chronic stimulation is unclear. Without axonal elongation during mTOR blockade, the associated increase in synapse formation cannot occur. However, this does not preclude an enabling role for mTOR in establishment of CST synapses.
Compared with one day of stimulation, 10 days of stimulation produced a further increase in mTOR signaling and expression of phosphorylated PTEN, which is an inactive form. We did not observe a significant change in PTEN phosphorylation levels after only one day stimulation, when mTOR signaling is increased. Possible PTEN-independent early mTOR activation is not surprising since mTOR signaling may be regulated by additional factors, including the protein Tuberin and its associated protein complex TSC (Inoki et al., 2002) . Briz et al. (2013) data show that 30 min exposure of hippocampal slice preparations to BDNF can activate mTOR by modulating Hamartin and Tuberin proteins. They found no decrease in phospho-PTEN or total PTEN levels in response to this BDNA treatment. This is similar to our observation of mTOR expression after 1 day of stimulation without concomitant changes in phopho-PTEN or total PTEN. After 10 days of MCX stimulation, total PTEN did not change, as would be expected with genetic ablation of PTEN. This helps to explain our observation of a lack of CST soma growth at the 10-day survival time. Although more experiments are needed to determine the kinetics and persistence of signaling changes, our findings suggest that chronic stimulation produces persistent mTOR activation and that this transitions CST neurons into a growth state, which may be marked by elevated phos-PTEN expression. This may be akin to the persistent downregulation of PTEN produced by gene ablation and associated increase in axon growth potential (Danilov and Steward, 2015; Du et al., 2015; Geoffroy et al., 2015; Gutilla et al., 2016; Jin et al., 2015; Lewandowski and Steward, 2014; Liu et al., 2010; Zukor et al., 2013) .
A role for Stat3 in CST synapse formation is consistent with previously reported evidence for a role in synapse formation in peripheral and central structures (Michalakis et al., 2013; Moon et al., 2013; Walker and Xu, 2014; Wang and Halvorsen, 1998) . Twelve weeks after Stat3 overexpression in mice there is elongation of ipsilateral axon collaterals from spared CST axons and partial functional improvement after unilateral pyramidal tract-lesion (Lang et al., 2013) . This study was conducted in animals with a unilateral pyramidal tract lesion. Using this injury model, sensitive anatomical assays reveal injury-dependent CST sprouting across the spinal cord midline (Brus-Ramer et al., 2007; Carmel et al., 2010; Maier et al., 2008) . If Stat3 over-expression enhances CST synapse formation without directly affecting axon elongation, as our finding suggests, this may help stabilize the injury-dependent axonal outgrowth by increasing the likelihood of target-derived trophic support (Singh and Miller, 2005) .
MCX electrical stimulation harnesses activity-dependent structural plasticity
In our previous studies, we found greater outgrowth with injury +stimulation compared to injury or stimulation alone (Brus-Ramer et al., 2007; Carmel et al., 2010) . By studying intact animals in the present study, we uncoupled injury-and activity-dependent CST outgrowth and, in doing so, we have shown a surprising distinction between the activation of mTOR and Stat3. Injury-dependent CST sprouting depends on mTOR upregulation in CST neurons (Lee et al., 2014) . Our finding shows how activity-and injury-dependent outgrowth may be coordinated at the molecular level by the additive or synergistic increase in mTOR levels, suggesting a common mechanism in the two axonal outgrowth paradigms. We used the activity marker, cFos expression, to verify the increase in activity resulting from MCX electrical stimulation and found cFos expression in non-neuronal cells, as well as in neurons. Similar observations were made after cerebellar electrical stimulation in rats, which resulted in cFos upregulation in astrocytes and radial glia (Tian and Bishop, 2002) . For our intended aim of elucidating neuron-intrinsic mechanism, we suggest that MCX stimulation triggers a growth program where the mTOR and the Jak/ Stat signaling pathways are both activated but work independently to promote CST axonal outgrowth and synapse formation, respectively. Consequently, cortical cFos expression alone is insufficient to drive a CST axonal growth condition. Further study is needed to elucidate other effects of increasing neural activity and the effect of the pattern of activation. The activation of numerous signaling pathways appears to be necessary for the various aspects of CST axonal remodeling and motor recovery (Moore et al., 2011; Sun and He, 2010) . Enhanced expression of a single signaling molecule may not recapitulate a neuron's optimal intrinsic growth program and produce insufficient plasticity to recover function after injury. Indeed, the differential and possibly independent roles of mTOR and Stat3 suggest that a single-gene approach would need to be supplemented by other interventions, such as aggressive behavioral therapy (Maier et al., 2008) , to achieve axonal outgrowth and synapse formation for motor recovery. Additionally, a growth program triggered by increased neuronal activity may be more physiologically relevant than genetic over-expression of individual components of the program. In this regard CST activity-dependent plasticity is recruited normally during development (Friel and Martin, 2007a) and skill learning in maturity (Kleim et al., 1998) .
Our prior findings established that electrical stimulation of the motor cortex or the CST leads to axonal sprouting and sufficient repair of the corticospinal motor system after injury to enable partial or complete recovery of motor function during development (Salimi et al., 2008) and in maturity (Carmel et al., 2010; Carmel et al., 2013; . With these studies, we were the first to show that a neuromodulatory approach that augments corticospinal system neuronal excitability/activity produces more than the expected short-term response plasticity (Brus-Ramer et al., 2007; Huang et al., 2005) , but rather produced durable strengthening of connections through significant CST axonal sprouting. Our working model is that MCX stimulation leads to activation of multiple signaling pathways. We have studied mTOR and Jak/Stat and show differential contributions to axonal outgrowth and CST synapse formation. MCX stimulation leads to motor recovery after pyramidal tract lesion (Carmel et al., 2010; without the need for behavioral rehabilitation (Maier et al., 2008) . Enhancing presynaptic site formation by MCX stimulation, driven by pStat3 upregulation, may overcome the burden of reduced connectivity after injury sufficiently to reduce the need for retraining a previously learned motor task after injury.
Motor cortex stimulation is a neuromodulatory approach that is readily translatable to the injured human because it may be implemented using non-invasive transcranial stimulation or minimally invasive with epidural stimulation (e.g., (Huang et al., 2005 ; Tronnier and Rasche, 2013)). As we move toward neuromodulatory approaches for clinical repair strategies, it is essential to understand the underlying mechanisms. Knowledge of the molecular mechanisms controlling stimulation-dependent sprouting can help researchers and clinicians advance brain stimulation and other neuromodulatory tools as new strategies for promoting axonal outgrowth in humans. Our findings provide strong evidence that motor cortex stimulation is an "electroceutical" (Famm et al., 2013) to upregulate signaling pathways for neural repair.
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